Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy entities : Poseida therapeutics, inc. save search
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.0%
H: 2.46%
C: 0.49%
day pipeline therapeutics therapy
Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
car-t therapeutics potential therapy
Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Published: 2024-03-19 (Crawled : 20:00) - prnewswire.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -1.03%
H: 6.94%
C: 3.13%
conference cell therapeutics therapy
CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $52.795 -3.02% -3.12% 300K
|
|
| O: 1.59%
H: 1.14%
C: -1.42%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 1.57%
H: 4.94%
C: 1.54%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -1.95%
BEAM | $22.74 -3.11% -3.21% 1M
|
Health Technology
|
| O: 1.88%
H: 0.88%
C: -2.79%
t-cell therapy growth study market
Manufacturing Approach in Cell Therapy as a Strategic Advantage
Published: 2024-01-17 (Crawled : 00:00) - poseida.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -1.06%
H: 5.71%
C: 1.79%
advantage cell therapy
Time for a Renaissance in Gene Editing and Gene Therapy
Published: 2023-11-15 (Crawled : 22:00) - poseida.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -0.45%
H: 0.91%
C: -2.27%
therapy
Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy
Published: 2023-08-07 (Crawled : 13:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 9.22%
H: 0.0%
C: -0.32%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 11.06%
H: 0.0%
C: -0.39%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 32.52%
H: 24.54%
C: -8.33%
cancer cell therapeutics therapy
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-CD19CD20-ALLO1, an Allogeneic Dual CAR-T Cell Therapy for B-Cell Malignancies
Published: 2023-07-05 (Crawled : 13:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 8.67%
H: 13.2%
C: -9.57%
cd19 fda drug cell clearance application car-t therapeutics therapy
Poseida Therapeutics Presents Encouraging Preclinical Data Across its Gene Therapy Programs at the American Society for Gene and Cell Therapy 2023 Annual Meeting
Published: 2023-05-18 (Crawled : 13:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.37%
H: 5.58%
C: -7.01%
cell preclinical meeting therapeutics therapy
Poseida Therapeutics Appoints Kristin Yarema, Ph.D., as President, Cell Therapy
Published: 2023-04-11 (Crawled : 16:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.74%
H: 0.74%
C: -3.32%
cell therapeutics therapy
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
Published: 2023-03-01 (Crawled : 00:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.18%
H: 1.4%
C: -6.14%
therapeutics therapy
Poseida Therapeutics to Present at H.C. Wainwright Cell Therapy Virtual Conference
Published: 2023-02-14 (Crawled : 16:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -0.8%
H: 6.32%
C: 3.49%
conference therapeutics therapy
Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & Exposition
Published: 2022-12-11 (Crawled : 16:20) - prnewswire.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
| Email alert
Add to watchlist
fviii-101 preclinical meeting therapeutics therapy
Poseida Therapeutics Announces Oral Presentation Highlighting P-FVIII-101 Gene Therapy at the 64th ASH Annual Meeting & Exposition
Published: 2022-11-03 (Crawled : 19:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -0.52%
H: 7.63%
C: 6.84%
fviii-101 meeting therapeutics presentation therapy
Global Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities
Published: 2022-08-12 (Crawled : 14:20) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.51%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.61%
H: 0.9%
C: 0.73%
BMY | $48.86 -0.27% 0.0% 16M
|
Health Technology
|
| O: 0.16%
H: 1.53%
C: 1.33%
DTIL | $9.81 -4.11% -4.28% 34K
|
Health Technology
|
| O: 0.61%
H: 23.78%
C: 22.56%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -1.7%
H: 12.62%
C: 8.91%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.42%
H: 0.45%
C: 0.4%
CABA | $12.94 -2.85% -2.94% 760K
|
Health Technology
|
| O: 2.76%
H: 4.7%
C: 2.68%
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: 3.58%
H: 1.99%
C: -1.41%
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.07%
H: 0.54%
C: -0.05%
global report funding therapy market
Renowned Geneticist to Chair Poseida Therapeutics Gene Therapy Scientific Advisory Board
Published: 2022-07-26 (Crawled : 13:20) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.37%
H: 0.37%
C: -1.49%
therapeutics therapy
Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy
Published: 2022-02-22 (Crawled : 21:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 1.78%
H: 0.25%
C: -9.5%
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: -1.13%
H: 3.33%
C: 1.75%
gene therapy therapeutics therapy
P-MUC1C-ALLO1: A Fully Allogeneic Stem Cell Memory T Cell (TSCM) CAR-T Therapy with Broad Potential in Solid Tumor
Published: 2021-11-16 (Crawled : 01:00) - poseida.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -1.39%
H: 0.0%
C: 0.0%
stem cell potential therapy car-t t-cell
Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control
Published: 2021-11-16 (Crawled : 01:00) - poseida.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: -1.39%
H: 0.0%
C: 0.0%
therapy car-t t-cell
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.